Xilio Therapeutics Logo in transparent PNG and SVG formats

Xilio Therapeutics Logo in large size

Xilio Therapeutics Logo icon format

Xilio Therapeutics Logo in large size for dark backgrounds

Xilio Therapeutics Logo icon format for dark backgrounds

About Xilio Therapeutics

Xilio Therapeutics, Inc., a clinical-stage biotechnology company, develops immunotherapies to improve the immune system of cancer patients. Its checkpoint inhibitor program includes XTX101, a clinical-stage, tumor-selective anti-CTLA-4 mAb that is in Phase 1/2 clinical trials in patients with solid tumors. The company also develops cytokine programs, which comprises XTX202, a modified form of IL-2; XTX301, an IL-12 product candidate; and XTX401, an IL-15 product candidate that are masked with a protein domain to prevent binding activity until cleaved off by tumor microenvironment (TME)-associated proteases. Xilio Therapeutics, Inc. was founded in 2016 and is headquartered in Waltham, Massachusetts.

Page last updated on:

calendar iconNovember 5th, 2021

Categories: